Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN358747 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Wnt1 Inducible Signaling Pathway Protein 3 (WISP3) (Middle Region) antibody
- Antibody type
- Polyclonal
- Description
- Affinity chromatography on Protein G
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- Middle Region
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at-20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.
WISP3 is a novel tumor suppressor gene of inflammatory breast cancer.
Variant WISPs as targets for gastrointestinal carcinomas.
Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia.
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors.
Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C, Currell B, Deuel B, Dowd P, Eaton D, Foster J, Grimaldi C, Gu Q, Hass PE, Heldens S, Huang A, Kim HS, Klimowski L, Jin Y, Johnson S, Lee J, Lewis L, Liao D, Mark M, Robbie E, Sanchez C, Schoenfeld J, Seshagiri S, Simmons L, Singh J, Smith V, Stinson J, Vagts A, Vandlen R, Watanabe C, Wieand D, Woods K, Xie MH, Yansura D, Yi S, Yu G, Yuan J, Zhang M, Zhang Z, Goddard A, Wood WI, Godowski P, Gray A
Genome research 2003 Oct;13(10):2265-70
Genome research 2003 Oct;13(10):2265-70
WISP3 is a novel tumor suppressor gene of inflammatory breast cancer.
Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D, Merajver SD
Oncogene 2002 May 9;21(20):3172-80
Oncogene 2002 May 9;21(20):3172-80
Variant WISPs as targets for gastrointestinal carcinomas.
Tanaka S, Sugimachi K, Shimada M, Maehara Y, Sugimachi K
Gastroenterology 2002 Jul;123(1):392-3
Gastroenterology 2002 Jul;123(1):392-3
Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia.
Hurvitz JR, Suwairi WM, Van Hul W, El-Shanti H, Superti-Furga A, Roudier J, Holderbaum D, Pauli RM, Herd JK, Van Hul EV, Rezai-Delui H, Legius E, Le Merrer M, Al-Alami J, Bahabri SA, Warman ML
Nature genetics 1999 Sep;23(1):94-8
Nature genetics 1999 Sep;23(1):94-8
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors.
Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen RL, Melhem MF, Finley GG, Quirke P, Goddard AD, Hillan KJ, Gurney AL, Botstein D, Levine AJ
Proceedings of the National Academy of Sciences of the United States of America 1998 Dec 8;95(25):14717-22
Proceedings of the National Academy of Sciences of the United States of America 1998 Dec 8;95(25):14717-22
No comments: Submit comment
No validations: Submit validation data